IRBM signs agreement with MD Anderson Cancer Center to generate novel immune-checkpoint monoclonal antibodies Read more
Citryll and Lonza Enter Into Partnership to Manufacture NETosis Inhibiting Antibody CIT-013 Read more
Thermo Fisher Scientific Signs Agreement with Lilly Oncology for Companion Diagnostic to be Used with RET Inhibitor Read more
Horizon secures FDA priority review for teprotumumab for treatment of active thyroid eye disease Read more
Ridgeback Biotherapeutics LP announces receipt of Breakthrough Therapy designation from FDA for mAb114 Read more